Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Incidence rates of some cancer types have risen in people under age 50
Researchers at the National Institutes of Health (NIH), USA, have completed a comprehensive analysis of…
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14…
Study finds structural barriers may prevent cancer care for people living with HIV
People living with HIV are less likely to receive potentially lifesaving cancer treatment if they…
ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
- ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
- ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated NSCLC
- ASCO 2024: Trial reveals benefits of ‘stepped’ palliative care for patients with advanced lung cancer
A new cancer treatment enters clinical trials in record time
This International Clinical Trials Day we are highlighting the first class research conducted at Peter MacCallum Cancer Centre from bench…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.